{"id":"nvp-1203-r","safety":{"commonSideEffects":[{"rate":"null","effect":"Pneumonitis"},{"rate":"null","effect":"Hypothyroidism"}]},"_chembl":{"chemblId":"CHEMBL585257","moleculeType":"Small molecule","molecularWeight":"467.35"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to PD-1, NVP-1203-R prevents the interaction between PD-1 and its ligands, leading to the activation of T cells and enhanced anti-tumor immune response.","oneSentence":"NVP-1203-R is a small molecule that targets the PD-1 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:23:38.132Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"}]},"trialDetails":[{"nctId":"NCT04082975","phase":"PHASE3","title":"Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain","status":"COMPLETED","sponsor":"NVP Healthcare","startDate":"2020-01-15","conditions":"Acute Low Back Pain","enrollment":421},{"nctId":"NCT03341832","phase":"PHASE2","title":"Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain","status":"COMPLETED","sponsor":"NVP Healthcare","startDate":"2018-01-31","conditions":"Acute Low Back Pain","enrollment":91}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NVP-1203-R","genericName":"NVP-1203-R","companyName":"NVP Healthcare","companyId":"nvp-healthcare","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NVP-1203-R is a small molecule that targets the PD-1 receptor. Used for Non-small cell lung cancer, PD-L1 positive.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}